Form 4 for COGT Cogent Biosciences, Inc.
Accepted 2022-07-01 00:00:00 ET · period of report 2022-06-30 · accession 0000899243-22-024711 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-07-01 | 2022-06-30 | COGT | Sachs Jessica | Chief Medical Off | A - Grant | $7.40 | +622 | 622 | New | +$4,603 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-30 | A | A | 622 | $7.40 | 622 | D | — | — | (F1) The shares were acquired under the Cogent Biosciences, Inc. 2018 Employee Stock Purchase Plan. The transaction is exempt under both Rule 16b-3(d) and Rule 16b-3(c). |